Vista Pharmaceuticals informs about trading window closure

30 Dec 2025 Evaluate
Vista Pharmaceuticals has informed that as per the Company's minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and pursuant to BSE Circular Ref No: LIST/COMP/01/2019-20 dated 02nd April,2019 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1st January, 2026 and will re-open after completion of 48 hours from the declaration of Un audited financial results for the quarter ending 31.12.2025 by the Board of Directors of the Company. Accordingly, all the Designated Persons and their immediate relatives are being intimated not to enter into any transaction involving dealing/trading in shares of the Company during the aforesaid period of closure of Trading Window Furthermore, the date of Board Meeting for considering the said Un Audited financial results for the quarter ending 31.12.2025 shall be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

8.38 0.18 (2.20%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×